Nordisk Pharmaceuticals Private Limited

Nordisk Pharmaceuticals Private Limited - healthcare in Rewa, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U85100MP2020PTC052942 Incorporated 22 September 2020 ROC Gwalior HQ Rewa, Madhya Pradesh, India
Active Private Limited Company healthcare MSME · Micro
Data last updated
Revenue · FY 2023
₹8.73 Lakh
▲ 16% YoY
Net profit · FY 2023
₹36,845
Net margin 4.2%
EBITDA · FY 2023
₹43,309
EBITDA margin 5%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Nordisk Pharmaceuticals Private Limited

Data last updated:

Nordisk Pharmaceuticals Private Limited is a private limited company based in Rewa, Madhya Pradesh, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 22 September 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U85100MP2020PTC052942. Its GSTIN is 23AAHCN1803A1Z9 (Madhya Pradesh).

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rahul Krishna Gupta and Ankit Krishna Gupta.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O. Rahul Krishna Gupta Indra Market, Rewa, Madhya Pradesh, India – 486001.

As per the financials filed for FY 2023, the company reported a revenue of ₹8.73 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹36,845 (net margin 4.2%) and EBITDA of ₹43,309 (EBITDA margin 5%).

Nordisk Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-38-0002032).

Company details

CIN U85100MP2020PTC052942
Registration Number 052942
Incorporation Date 22 September 2020
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MP-38-0002032
Key People
Rahul Krishna Gupta Director Ankit Krishna Gupta Director

Recognitions & Rankings of Nordisk Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MP-38-0002032

Contact details

Nordisk Pharmaceuticals Private Limited's registered office is in Rewa, Madhya Pradesh. Its e-mail address is in the company report.

  • Email
  • Registered Address
    C/O. Rahul Krishna Gupta Indra Market, Rewa, Madhya Pradesh, India – 486001
  • Industry
    Healthcare, Human Health Activities

To see the full contact details of Nordisk Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Nordisk Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Nordisk Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Nordisk Pharmaceuticals Private Limited, buy the company report.

Financials of Nordisk Pharmaceuticals Private Limited

FY 2025 filings available

Nordisk Pharmaceuticals Private Limited reported revenue of ₹8.73 Lakh (up 16% YoY) for FY 2023.

Revenue · FY 2023
₹8.73 Lakh ▲ 16%
Net profit · FY 2023
₹36,845 margin 4.2%
EBITDA · FY 2023
₹43,309 margin 5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 16%

Revenue rose 16% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹43,309
Profit Before Tax
Tax Expense
Net Profit (PAT)₹36,845
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin5%
Net Profit Margin4.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Nordisk Pharmaceuticals Private Limited, buy the company report.

Board of directors of Nordisk Pharmaceuticals Private Limited

Nordisk Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Rahul Krishna GuptaDirector22 Sep 20206 Years 1 MonthsCurrent
Ankit Krishna Gupta
Also directs: Vrindabihari Ingot Private Limited, Maaambeydevi Infratransport Services Private Limited, Seth Champaran House Private Limited
Director22 Sep 20206 Years 1 MonthsCurrent
View all directors

Peer comparison

Nordisk Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Genastro Pharmaceuticals Private Limited₹8.78 Lakh (FY 2025)41.0%Delhi, India
Ealder Pharmaceuticals Private Limited₹8.78 Lakh (FY 2023)21.0%Ashiana Nagar, Bihar, India
Groove Pharmaceuticals Private Limited₹8.75 Lakh (FY 2024)-27.0%Mandir, Chembur (W), Maharashtra, India
Nordisk Pharmaceuticals Private Limitedthis company₹8.73 Lakh (FY 2023)₹36,8454.2%16.0%Rewa, Madhya Pradesh, India
Glowchem Pharmaceuticals Private Limited₹8.7 Lakh (FY 2016)10.0%Gopalganj, Bihar, India
Litman Pharmaceuticals Private Limited₹8.68 Lakh (FY 2024)59.0%Bangalore, Karnataka, India

To see the full peer comparison of Nordisk Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Nordisk Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Nordisk Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 08, 2024.

Active EPFO establishments
1

GST

Nordisk Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AAHCN1803A1Z9Madhya PradeshActive22 Feb 2021

To see the full GST registrations and return filing status of Nordisk Pharmaceuticals Private Limited, buy the company report.

Recent activity

Nordisk Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Ankit Krishna Gupta was appointed as Director on 22 Sep 2020.

AGM
Nordisk Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nordisk Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Appointed
Ankit Krishna Gupta was appointed as Director.
Appointed
Rahul Krishna Gupta was appointed as Director.
Incorporation
22 Sep 2020
Nordisk Pharmaceuticals Private Limited was registered on 22 Sep 2020 with Roc Gwalior & aged 6 years 1 month as per MCA records.

Frequently asked questions

Nordisk Pharmaceuticals is an active private limited company based in Rewa, Madhya Pradesh, India. The company works in human health activities, within the healthcare industry. It was incorporated on 22 September 2020 (6+ years old) and is registered under CIN U85100MP2020PTC052942.

Nordisk Pharmaceuticals has 2 current directors:

The latest financial statements of Nordisk Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Nordisk Pharmaceuticals is 23AAHCN1803A1Z9, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Nordisk Pharmaceuticals is U85100MP2020PTC052942. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nordisk Pharmaceuticals was incorporated on 22 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.

The peers of Nordisk Pharmaceuticals by revenue are Genastro Pharmaceuticals Private Limited, Ealder Pharmaceuticals Private Limited, Groove Pharmaceuticals Private Limited, Glowchem Pharmaceuticals Private Limited, Litman Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Ankit Krishna Gupta was appointed as Director on 22 Sep 2020. Rahul Krishna Gupta was appointed as Director on 22 Sep 2020.

Yes, Nordisk Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-38-0002032).

The registered office of Nordisk Pharmaceuticals is at CO. Rahul Krishna Gupta Indra Market, Rewa, Madhya Pradesh, India – 486001.

Nordisk Pharmaceuticals operates in the healthcare industry, in the human health activities segment.